.
ResMed Inc. (ASX:RMD, NYSE:RMD) has announced an annual profit boost of 12 per cent, underpinned by growth from its US markets.
The manufacturer and distributor of medical equipment generated a net profit of $254.9 million, an increase of more than $25 million from the previous financial year.
Resmed says American revenue lifted by 13 per cent in the fourth quarter while revenue from the rest of the business grew by 3 per cent over the year.
In the first half of the 2012 financial year ResMed reported a net profit of $112.6 million.
News: ResMed FY12 profit up 12%
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$38.15 |
Change
0.070(0.18%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $38.10 | $38.22 | $37.91 | $30.20M | 792.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 956 | $38.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $38.15 | 2018 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
